Buscar
16/05/2022
Comparison of the Results of a Parkinson's Holter Monitor With Patient Diaries, in Real Conditions of Use: A Sub-analysis of the MoMoPa-EC Clinical Trial
Pérez-López C., Hernández-Vara J., Caballol N., Bayes À., Buongiorno M., Lopez-Ariztegui N., Gironell A., López-Sánchez J., Martínez-Castrillo J.C., Sauco M A., López-Manzanares L., Escalante-Arroyo S., Pérez-Martínez D.A., Rodríguez-Molinero A.. Comparison of the Results of a Parkinson's Holter Monitor With Patient Diaries, in Real Conditions of Use: A Sub-analysis of the MoMoPa-EC Clinical Trial. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.835249. PMID:35651347. IF:3.400(Q2/5D).
16/05/2022
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Quindós G., Miranda-Cadena K., San-Millán R., Borroto-Esoda K., Cantón E., Linares-Sicilia M.J., Hamprecht A., Montesinos I., Tortorano A.M., Prigitano A., Vidal-García M., Marcos-Arias C., Guridi A., Sanchez-Reus F., Machuca-Bárcena J., Rodríguez-Iglesias M.A., Martín-Mazuelos E., Castro-Méndez C., López-Soria L., Ruiz-Gaitán A., Fernandez-Rivero M., Lorenzo D., Capilla J., Rezusta A., Pemán J., Guarro J., Pereira J., Pais C., Romeo O., Ezpeleta G., Jauregizar N., Angulo D., Eraso E.. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study. Frontiers in Cellular and Infection Microbiology. 2022; 12DOI:10.3389/fcimb.2022.906563. PMID:35651755. IF:5.700(Q1/3D).
15/05/2022
Early Discontinuation of Antithrombotic Treatment Following Left Atrial Appendage Closure
Mesnier, J, Cruz-Gonzalez, I, Arzamendi, D, Freixa, X, Nombela-Franco, L, Peral, V, Caneiro-Queija, B, Mangieri, A, Trejo-Velasco, B, Asmarats, L, Regueiro, A, McInerney, A, Mas-Llado, C, Estevez-Loureiro, R, Laricchia, A, O'Hara, G, Rodes-Cabau, J. Early Discontinuation of Antithrombotic Treatment Following Left Atrial Appendage Closure. AMERICAN JOURNAL OF CARDIOLOGY. 2022; 171DOI:10.1016/j.amjcard.2022.01.055. PMID:35317927. IF:2.800(Q3/6D).
14/05/2022
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV) a randomised controlled trial
Delgado-Lista J., Alcala-Diaz J.F., Torres-Peña J.D., Quintana-Navarro G.M., Fuentes F., Garcia-Rios A., Ortiz-Morales A.M., Perez-Caballero A.I., Yubero-Serrano E.M., Rangel-Zuñiga O.A., Camargo A., Rodriguez-Cantalejo F., Lopez-Segura F., Badimon L., Ordovas J.M., Perez-Jimenez F., Perez-Martinez P., Lopez-Miranda J., Almaden Peña Y., Aranda E., Arenas de Larriva A.P., Badimon J.J., Blanco-Molina A., Blanco-Rojo R., Bolivar-Muñoz J., Caballero-Villarraso J., Chica J., Corina A., Criado-Garcia J., Cruz-Teno C., Daponte-Codina A., de Teresa Galvan E., Delgado-Casado N., Estruch R., Fernandez J.M., Fernandez-Gandara C., Fuentes-Jimenez F., Garcia-Carpintero Fernandez-Pacheco S., Gomez-Delgado F., Gomez-Garduño A., Gomez-Luna P., Gomez-Luna M.J., Gonzalez-Guardia L., Gonzalez-Requero A.I., Gutierrez-Mariscal F.M., Haro-Mariscal C.M., Jimenez-Lucena R., Jimenez-Morales A.I., Leon-Acuña A., Marin-Hinojosa C., Meneses Alvarez M.E., Mesa-Luna D., Moya-Garrido M.N., Muñoz-Carvajal I., Navarro-Martos V., Ochoa J.J., Ortiz-Minuesa J.A., Pan M., Peña-Orihuela P., Perez-Corral I., Pi-Sunyer F.X., Ramirez-Lara I., Rodriguez-Artalejo F., Romero M.A., Roncero-Ramos I., Ruano-Ruiz J.A., Ruiz de Castroviejo J., Sanchez-Villegas P., Suarez de Lezo J., Vals-Delgado C., Valverde R., Visioli F.. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV) a randomised controlled trial. LANCET. 2022; 399(10338)DOI:10.1016/S0140-6736(22)00122-2. PMID:35525255. IF:168.900(Q1/1D).